Alison Stevenson, Managing Director and Head of R&D at Tor-Bac, explains why this single-dose product has experienced year-on-year sales growth since its introduction to the UK market in 2018.
Stevenson explains: “Practitioners offering injectable procedures are familiar with using bacteriostatic saline to reconstitute medicinal products for intramuscular or intradermal injection.”
Tor-Bac is a preserved bacteriostatic saline solution containing sodium chloride 9mg and 0.9% (9mg/ml) benzyl alcohol. The benzyl alcohol provides both bacteriostatic protection and reduced injection-site pain when compared with ordinary saline.¹ Evidence has shown that, since 1928, more than 60 studies have reported significantly lower pain scores when benzyl alcohol is present in saline solutions, supporting the use of bacteriostatic saline in clinical practice.²
Tor-Bac as a 5ml SINGLE use ampoule is both easy to use and easy to transport between clinics. As a high-quality product manufactured within a Medicines and Healthcare products Regulatory Agency (MHRA) approved facility in the UK, it is…
